Similar Search Results

Intellectual Property Rights and Innovation : Evidence from the Human Genome

Williams, Heidi L. - 2010

Do intellectual property (IP) rights on existing technologies hinder subsequent innovation? Using newly-collected data …'s short-term IP had persistent negative effects on subsequent innovation relative to a counterfactual of Celera genes having …

Persistent link: https://www.econbiz.de/10012462442

Risks to the Returns to Medical Innovation : The Case of Myriad Genetics

Clemens, Jeffrey - 2015

discuss the implications of the risks we analyze for the total volume of medical innovation and for its organization across …

Persistent link: https://www.econbiz.de/10012457199

Dynamic Efficiency and Pricing of Innovations with Insurance : The Case for Gene Therapies

Basu, Anirban - National Bureau of Economic Research - 2024

I demonstrate that to achieve dynamic efficiency, the optimal share of total surplus that a social payer should transfer to an innovating industry for a current asset depends on the marginal product of investment and the share of profits invested by the industry on the current asset and not on...

Persistent link: https://www.econbiz.de/10014544758

Bubbles and the Value of Innovation

Haddad, Valentin; Ho, Paul; Loualiche, Erik - National Bureau of Economic Research - 2022

document two ways the market valuation of innovation and its economic impact become disconnected during bubbles. Specifically … firms will succeed that reconciles both the facts, unlike existing models of bubbles. Optimal innovation policy during …Booming innovation often coincides with intense speculation in financial markets. Using over a million patents, we …

Persistent link: https://www.econbiz.de/10013191012

Adoption Curves and Social Interactions

Brock, William A. - 2009

This paper considers the observational implications of social influences on adoption decisions for an environment of perfect foresight adopters. We argue that social influences can produce two observable effects: 1) discontinuities in unconditional adoption curves and 2) pattern reversals in...

Persistent link: https://www.econbiz.de/10012463584

(Co-)Working in Close Proximity : Knowledge Spillovers and Social Interactions

Roche, Maria P.; Oettl, Alexander; Catalini, Christian - National Bureau of Economic Research - 2022

We examine the influence of physical proximity on between-startup knowledge spillovers at one of the largest technology co-working hubs in the United States. Relying on the random assignment of office space to the hub's 251 startups, we find that proximity positively influences knowledge...

Persistent link: https://www.econbiz.de/10013334339

Damages and Injunctions in the Protection of Proprietary Research Tools

Schankerman, Mark - 1999

Profit on proprietary research tools is determined partly by the remedies for infringement, such as damages and injunctions. We investigate how damages under a liability rule and the opportunity for injunctions under a property rule can affect the incentives to develop research tools. We show...

Persistent link: https://www.econbiz.de/10012471710

The Value of Pharmacogenomic Information

Graves, John A. - 2017

Pharmacogenomics, or the application of genetic testing to guide drug selection and/or dosing, is often cited as integral to the vision of how precision medicine can be integrated into routine clinical practice. Yet despite a growing base of scientific discovery on genetic variation that...

Persistent link: https://www.econbiz.de/10012453580

Genetic Adverse Selection : Evidence from Long-Term Care Insurance and Huntington Disease

Oster, Emily - 2009

Individual, personalized genetic information is increasingly available, leading to the possibility of greater adverse selection over time, particularly in individual-payer insurance markets; this selection could impact the viability of these markets. We use data on individuals at risk for...

Persistent link: https://www.econbiz.de/10012463324

The Future of Drug Development : The Economics of Pharmacogenomics

Vernon, John A. - 2005

This paper models how the evolving field of pharmacogenomics (PG), which is the science of using genomic markers to predict drug response, may impact drug development times, attrition rates, costs, and the future returns to research and development (R&D). While there still remains an abundance...

Persistent link: https://www.econbiz.de/10012466796

1
2
3
4
5
6
7
8
9
10
Next
Last